These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21076402)

  • 1. Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies.
    Frey G; Chen J; Rits-Volloch S; Freeman MM; Zolla-Pazner S; Chen B
    Nat Struct Mol Biol; 2010 Dec; 17(12):1486-91. PubMed ID: 21076402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of HIV-1 gp41-directed neutralizing and non-neutralizing fragment antibody binding domain (Fab) and single chain variable fragment (ScFv) antibodies to the ectodomain of gp41 in the pre-hairpin and six-helix bundle conformations.
    Louis JM; Aniana A; Lohith K; Sayer JM; Roche J; Bewley CA; Clore GM
    PLoS One; 2014; 9(8):e104683. PubMed ID: 25105806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region.
    Nicely NI; Dennison SM; Spicer L; Scearce RM; Kelsoe G; Ueda Y; Chen H; Liao HX; Alam SM; Haynes BF
    Nat Struct Mol Biol; 2010 Dec; 17(12):1492-4. PubMed ID: 21076400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41.
    Gustchina E; Bewley CA; Clore GM
    J Virol; 2008 Oct; 82(20):10032-41. PubMed ID: 18667502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody.
    Kong R; Xu K; Zhou T; Acharya P; Lemmin T; Liu K; Ozorowski G; Soto C; Taft JD; Bailer RT; Cale EM; Chen L; Choi CW; Chuang GY; Doria-Rose NA; Druz A; Georgiev IS; Gorman J; Huang J; Joyce MG; Louder MK; Ma X; McKee K; O'Dell S; Pancera M; Yang Y; Blanchard SC; Mothes W; Burton DR; Koff WC; Connors M; Ward AB; Kwong PD; Mascola JR
    Science; 2016 May; 352(6287):828-33. PubMed ID: 27174988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies.
    Pejchal R; Gach JS; Brunel FM; Cardoso RM; Stanfield RL; Dawson PE; Burton DR; Zwick MB; Wilson IA
    J Virol; 2009 Sep; 83(17):8451-62. PubMed ID: 19515770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the probability of polyreactive antibodies 4E10 and 2F5 disabling a gp41 trimer after T cell-HIV adhesion.
    Hu B; Liao HX; Alam SM; Goldstein B
    PLoS Comput Biol; 2014 Jan; 10(1):e1003431. PubMed ID: 24499928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions.
    Buzon V; Natrajan G; Schibli D; Campelo F; Kozlov MM; Weissenhorn W
    PLoS Pathog; 2010 May; 6(5):e1000880. PubMed ID: 20463810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexes of neutralizing and non-neutralizing affinity matured Fabs with a mimetic of the internal trimeric coiled-coil of HIV-1 gp41.
    Gustchina E; Li M; Ghirlando R; Schuck P; Louis JM; Pierson J; Rao P; Subramaniam S; Gustchina A; Clore GM; Wlodawer A
    PLoS One; 2013; 8(11):e78187. PubMed ID: 24244293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.
    Chakrabarti BK; Pancera M; Phogat S; O'Dell S; McKee K; Guenaga J; Robinson J; Mascola J; Wyatt RT
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):877-87. PubMed ID: 21158699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity.
    Rubio AA; Filsinger Interrante MV; Bell BN; Brown CL; Bruun TUJ; LaBranche CC; Montefiori DC; Kim PS
    J Virol; 2021 Jul; 95(15):e0235020. PubMed ID: 33980592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex.
    Dawood R; Benjelloun F; Pin JJ; Kone A; Chanut B; Jospin F; Lucht F; Verrier B; Moog C; Genin C; Paul S
    AIDS; 2013 Mar; 27(5):717-30. PubMed ID: 23719346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration.
    Qiao ZS; Kim M; Reinhold B; Montefiori D; Wang JH; Reinherz EL
    J Biol Chem; 2005 Jun; 280(24):23138-46. PubMed ID: 15833740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
    Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
    J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41.
    Gustchina E; Li M; Louis JM; Anderson DE; Lloyd J; Frisch C; Bewley CA; Gustchina A; Wlodawer A; Clore GM
    PLoS Pathog; 2010 Nov; 6(11):e1001182. PubMed ID: 21085615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of a putative gp41 dimerization domain in human immunodeficiency virus type 1 membrane fusion.
    Liu J; Deng Y; Li Q; Dey AK; Moore JP; Lu M
    J Virol; 2010 Jan; 84(1):201-9. PubMed ID: 19846514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.
    Luftig MA; Mattu M; Di Giovine P; Geleziunas R; Hrin R; Barbato G; Bianchi E; Miller MD; Pessi A; Carfí A
    Nat Struct Mol Biol; 2006 Aug; 13(8):740-7. PubMed ID: 16862157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
    J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HIV membrane in neutralization by two broadly neutralizing antibodies.
    Alam SM; Morelli M; Dennison SM; Liao HX; Zhang R; Xia SM; Rits-Volloch S; Sun L; Harrison SC; Haynes BF; Chen B
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20234-9. PubMed ID: 19906992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.
    Zhang MY; Vu BK; Choudhary A; Lu H; Humbert M; Ong H; Alam M; Ruprecht RM; Quinnan G; Jiang S; Montefiori DC; Mascola JR; Broder CC; Haynes BF; Dimitrov DS
    J Virol; 2008 Jul; 82(14):6869-79. PubMed ID: 18480433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.